Dr Trevor Nicholls
Senior Independent Non-Executive Director
Appointment to the Board:
Dr Trevor Nicholls was appointed to the hVIVO Board as a Non-Executive Director in May 2014.
Experience and expertise
Trevor is a professional Company Director with over 35 years of building international businesses in the life science industry, with a focus on genomics in major pharma, biotech and academic clients. Prior to joining CABI Trevor was Chief Commercial Officer for Affymetrix Inc with accountability for Sales, Marketing, Product Development and Manufacturing. Prior to this, he was founder CEO of Oxagen Ltd where he raised a total of £50 million over three venture-backed financing rounds and secured commercial partnerships in addition to academic collaborations. A major part of his early career was with Amersham International (now part of GE Healthcare) covering diagnostics and radiopharmaceuticals as well as research products. He has also worked as a consultant with McKinsey and Company Inc. and in Marketing with Unilever. Trevor holds a BA and D.Phil in biochemistry from the University of York and diploma qualifications in marketing (CIM) and company directorship.
Current external appointments
Trevor is currently Chief Executive Officer at CABI and a Non-Executive Director at Avacta Group plc, Iota Sciences Ltd and Conidia Bioscience Ltd.